GENETRON HOLDINGS LIMITED

(GTH)
  Report
Delayed Nasdaq  -  05/17 04:00:00 pm EDT
1.550 USD   +6.16%
04/21BTIG Adjusts Genetron Holdings' Price Target to $10 From $17, Keeps Buy Rating
MT
04/19Genetron Obtains CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit
MT
04/19Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD«
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Technical AnalysisHistorical ChartNews ChartSector ChartComparison ChartReversed ChartRelative Strength Chart
News chart Genetron Holdings Limited